Patent details
EP1096932 Title: ANTIHYPERTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CHANNEL BLOCKER
Basic Information
- Publication number:
- EP1096932
- PCT Application Number:
- PCT/EP/1999/004842
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP999346471
- PCT Publication Number:
- WO/2000/002543
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTIHYPERTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CHANNEL BLOCKER
- French Title of Invention:
- COMBINAISON ANTIHYPERTENSIVE A BASE DE VALSARTAN ET D'UN BLOQUANT DU CANAL DE CALCIUM
- German Title of Invention:
- BLUTHOCHDRUCKGEGENMITTELKOMBINATION DES VALSARTAN UND KALZIUMKANAL BLOCKER
- SPC Number:
-
91358
Dates
- Filing date:
- 09/07/1999
- Grant date:
- 29/08/2007
- EP Publication Date:
- 29/08/2007
- PCT Publication Date:
- 20/01/2000
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/05/2001
- EP B1 Publication Date:
- 29/08/2007
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 09/07/2019
- Renunciation date:
- Revocation date:
- 26/10/2015
- Annulment date:
Owner
- From:
- 09/07/1999
- Name:
- Novartis Pharma AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- de GASPARO Marc
- Address:
- Switzerland (CH)
2
- Name:
- WEBB Randy, Lee
- Address:
- United States (US)
Priority
- Priority Number:
- 113893
- Priority Date:
- 10/07/1998
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/41;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 25/06/2015
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- MARKS & CLERK LLP
| Filing date | Document type | Number of pages |
|---|